Published financial brief
1771B
DOLBY LABORATORIES INC
- As of
- 2025-09-30
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20212021-09-30 | FY 20222022-09-30 | FY 20232023-09-30 | FY 20242024-09-30 | FY 20252025-09-30 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 1,281.3 | 1,253.8 | 1,299.7 | 1,273.7 | 1,349.1 |
| Cost of goods soldUSD millions | 34.2 | 57.4 | 76.6 | 75.2 | 83.4 |
| Selling, general and administrative expenseUSD millions | 810.5 | 856.3 | 877.8 | 851.8 | 899.8 |
| Depreciation and amortizationUSD millions | 95.9 | 88.5 | 82.6 | 75.6 | 87.8 |
| Net incomeUSD millions | 310.2 | 184.1 | 200.7 | 261.8 | 255 |
| Operating profit (EBIT)USD millions | 340.8 | 251.6 | 262.8 | 271.1 | 278.2 |
| Income taxesUSD millions | 36.7 | 31.4 | 48.4 | 48.2 | 47 |
| Short-term debtUSD millions | 15.4 | 13.3 | 13.6 | 12.2 | 10.4 |
| Long-term debtUSD millions | 56.7 | 37.7 | 37 | 34.8 | 28.5 |
| Cash and equivalentsUSD millions | 1,271.9 | 817.6 | 957.1 | 577.8 | 794.1 |
| ReceivablesUSD millions | 414.9 | 419.7 | 444.4 | 512.9 | 511.9 |
| InventoryUSD millions | 11 | 23.5 | 35.6 | 33.7 | 30.4 |
| PayablesUSD millions | 17.8 | 14.2 | 20.9 | 17.4 | 17.8 |
| Net property, plant and equipmentUSD millions | 601.5 | 560 | 521.8 | 518.2 | 503.8 |
| Capital expenditureUSD millions | 54.5 | 47.9 | 30.3 | 30 | 36.3 |
| Operating cash flowUSD millions | 447.8 | 318.6 | 367.1 | 327.3 | 472.2 |
| Prepaid expensesUSD millions | 30 | 26.9 | 24.4 | 29.7 | 28 |
| AccrualsUSD millions | 189.9 | 167.1 | 200.9 | 191.1 | 202.9 |
| EBITDAUSD millions | 436.6 | 340.1 | 345.4 | 346.7 | 366 |
| Working capitalUSD millions | 1,444.8 | 1,033.4 | 1,065.6 | 776.6 | 950.5 |
| Working capital requirementUSD millions | 408.1 | 429.1 | 459.1 | 529.3 | 524.5 |
| Total debtUSD millions | 72.1 | 50.9 | 50.6 | 47 | 38.9 |
| Free cash flowUSD millions | 393.3 | 270.7 | 336.7 | 297.3 | 435.9 |
| Unlevered free cash flowUSD millions | 293.4 | 234.5 | 234.1 | 204.7 | 291.4 |
| Returns and ratios | |||||
| ROICratio | 16.8% | 11.7% | 10.8% | 9% | 9.5% |
| Pre-tax ROICratio | 18.8% | 13.7% | 13.4% | 10.6% | 11.2% |
| Effective tax rateratio | 10.3% | 14.6% | 19.4% | 15.4% | 15.5% |
| Revenue growthratio | 10.3% | -2.1% | 3.7% | -2% | 5.9% |
| EBIT / Revenueratio | 26.6% | 20.1% | 20.2% | 21.3% | 20.6% |
| Revenue / Invested capitalmultiple | 0.71× | 0.68× | 0.66× | 0.5× | 0.54× |
| Cogs Over Revenuesratio | 2.7% | 4.6% | 5.9% | 5.9% | 6.2% |
| Sga Over Revenuesratio | 63.3% | 68.3% | 67.5% | 66.9% | 66.7% |
| Da Over Revenuesratio | 7.5% | 7.1% | 6.4% | 5.9% | 6.5% |
| Nfa Over Revenuesratio | 46.9% | 44.7% | 40.1% | 40.7% | 37.3% |
| Wcr Over Revenuesratio | 31.9% | 34.2% | 35.3% | 41.6% | 38.9% |
| Debt Over Ebitdamultiple | 0.17× | 0.15× | 0.15× | 0.14× | 0.11× |
| St Debt Over Cashmultiple | 0.01× | 0.02× | 0.01× | 0.02× | 0.01× |
| Interest Over Ebitdamultiple | 0× | 0× | —missing | —missing | —missing |
| Interest Over Nocf Nicfmultiple | 0× | 0× | —missing | —missing | —missing |
| Nsf Over Wcrmultiple | -3.08× | -1.87× | -2.06× | -1.07× | -1.49× |
Ask this snapshot
Research assistant
1771B · annualSnapshot 7aab651a
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000